Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis

Jayoon Moon1,2, Junseok Lee1,3, Mee Kum Kim1,2

  • 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Cornea
|August 29, 2022
PubMed

Insights

Pediatric blepharokeratoconjunctivitis (BKC) often resolves with treatment, but recurrence is common. Recurrence significantly increases astigmatism, highlighting the need for vigilant monitoring and prompt management in children with BKC.

Area of Science:

  • Ophthalmology
  • Pediatric ophthalmology
  • Corneal diseases

Background:

  • Blepharokeratoconjunctivitis (BKC) is an inflammatory eye condition affecting children.
  • Understanding its clinical course and outcomes is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical characteristics, disease progression, treatment efficacy, and prognostic factors in pediatric patients diagnosed with BKC.
  • To identify factors associated with recurrence and visual outcomes.

Main Methods:

  • Retrospective review of medical charts for 137 pediatric patients (≤15 years) diagnosed with BKC between 2004 and 2020.
  • Data collected included demographics, ocular findings, corneal lesion characteristics, treatment, and outcomes.

Main Results:

  • The most frequent corneal lesion was neovascularization (77.4%), followed by infiltration (51.8%) and scarring (43.1%).
  • Disease remission was achieved in 95% of patients, with significant visual acuity improvement (P = 0.001).
  • Recurrence affected 52.6% of patients, and was positively associated with higher final cylinder power.

Conclusions:

  • While 95% of pediatric BKC cases achieved remission, over half experienced recurrence.
  • Recurrence was linked to significant astigmatism, emphasizing the importance of ongoing observation.
  • Prompt management and monitoring are essential for preserving vision in children with BKC.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...